Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,368.85
(
-1.67%
)
US TECH 100
22,405.20
(
-2.38%
)
Dow Jones
45,166.64
(
-1.73%
)
Brent Oil
106.89
(
0.00%
)
Bitcoin
66,400.49
(
0.12%
)
News Focus
News Focus

Replies to post #1962 on Enanta Pharmaceuticals Inc (ENTA)

Replies to #1962 on Enanta Pharmaceuticals Inc (ENTA)
icon url

DewDiligence

05/19/21 3:16 PM

#1963 RE: DewDiligence #1962

ENTA’s_enterprise value_at_the_current_share_ price ($48.59) is ~$740M, based on 24.1M fully-diluted shares (#msg-163910230) and pro forma cash of $426.1M (#msg-163910195).
icon url

DewDiligence

08/09/21 4:45 PM

#2000 RE: DewDiligence #1962

ENTA’s fully-diluted share count @6/30/21=24.1M—unchanged since 3/31/21 (#msg-163910230).

The 24.1M figure above consists of: 20.2M basic shares on the 6/30/21 balance sheet (https://www.sec.gov/ix?doc=/Archives/edgar/data/1177648/000156459021042612/enta-10q_20210630.htm#CONSOLIDATED_BALANCE_SHEETS ); and 3.9M options outstanding at 6/30/21 (whether or not exercisable) (ibid, page 13).